DNMT3A and atherosclerosis: Insights from both human and animal studies have demonstrated that mutations associated with CHIP, particularly in TET2 and DNMT3A, reprogram innate immune cells such as monocytes and macrophages toward a persistently pro-inflammatory phenotype, thereby promoting atherosclerosis and other cardiovascular diseases39,40 (Figure 1).